June 7, 2000 Customers Here are some of our current or past customers. Biotechs & Pharmas CROs & Service Companies Laboratories & Research institutions Clinical institutions READ MORE
October 27, 2020 COVID-19 : monitoring the outbreak progression Since the very early days of COVID-19 outbreak in Belgium, DNAlytics has been working with academic experts and public authorities towards objective, data-driven public health policies. Partners The project has… READ MORE
October 27, 2020 COVID-19 : mastering the risk of contagion Since the very early days of COVID-19 outbreak in Belgium, DNAlytics has been working with academic experts and public authorities towards objective, data-driven public health policies. This second set of… READ MORE
February 5, 2019 Management of severe food allergies Partner DBV Technologies is a global clinical stage biopharmaceutical company developing a novel class of immunotherapy against food allergies. Their investigational treatment portfolio is built over Viaskin® platform, a… READ MORE
November 27, 2018 Pathogenic mutations in G-6-PD gene Partner ZenTech is a Belgian biotech company specialized in the diagnosis of pathologies arising in the early life stages. ZenTech develops, produces and sales immunoassay screening IVD kits based… READ MORE
October 23, 2018 Identification of biomarkers for innovative oncology prodrug Partner Convert Pharmaceuticals is a preclinical-stage company that builds a proprietary drug pipeline exploiting specific actors of the tumor micro-environment or therapeutic benefit. Convert’s lead product CP-506 is a hypoxia-activated… READ MORE
June 7, 2018 Hemorrhagic Risk Scoring System in Cirrhotic Children – HRS²C² Partner Cliniques Universitaires Saint-Luc in Brussels, Belgium, is the clinical institution associated to the Medical School of Université catholique de Louvain – UCL. Its different departments are delivering cutting-edge medical… READ MORE
June 5, 2018 Multifactorial stratification Context Often in clinical trials for the validation of a drug, one has to compare a test and a control arms. Although setting up and implementing a traditional clinical trial… READ MORE
June 5, 2018 Immunotherapy response prediction Context A few years ago, the pharmaceutical company GSK developed immuno-therapies against several forms of cancer. One of them, was a therapeutic vaccine targeting melanoma. Within a Phase II trial,… READ MORE
June 5, 2018 Osteoarthritis Prognosis Context Patients with osteoarthritis (OA) can be roughly divided in two categories. A majority of them (70-90%) will have a mild/moderate progression of their disease, spreading over more than 10… READ MORE
June 5, 2018 RheumaKit RheumaKit is a set of tools for the management of patients with arthritis, enabling differential diagnosis with RheumaKit-Dx, patient monitoring and clinical studies management with RheumaKit-Timeline (for rheumatologist) and RheumaKit… READ MORE